Cargando…

Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens

BACKGROUND AND OBJECTIVE: COPD exacerbation is characterized by worsening of symptoms, warranting change in treatment. Systemic and airway inflammation play roles in the pathogenesis of COPD exacerbation. We hypothesized whether increased serum inflammatory biomarkers are associated with the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamatawong, Theerasuk, Apiwattanaporn, Apitch, Siricharoonwong, Warisara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459973/ https://www.ncbi.nlm.nih.gov/pubmed/28615935 http://dx.doi.org/10.2147/COPD.S132132

Ejemplares similares

Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients
por: Kawamatawong, Theerasuk, et al.
Publicado: (2018)

Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
por: Kawamatawong, Theerasuk
Publicado: (2021)

Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases
por: Kawamatawong, Theerasuk, et al.
Publicado: (2017)

Critically ill patients with edema and ascites may experience subtherapeutic anti-factor Xa levels following abdominal subcutaneous enoxaparin treatment
por: Tharanon, Vichapat, et al.
Publicado: (2022)

Assessment of proximal and peripheral airway dysfunction by computed tomography and respiratory impedance in asthma and COPD patients with fixed airflow obstruction
por: Pornsuriyasak, Prapaporn, et al.
Publicado: (2018)

Role of eosinophilic inflammation and atopy in elderly asthmatic patients
por: Kawamatawong, Theerasuk, et al.
Publicado: (2016)

Erratum: Correction of Figure 1: The asthma and chronic obstructive pulmonary disease overlap syndrome in tertiary care setting Thailand
por: Kawamatawong, Theerasuk, et al.
Publicado: (2018)

The asthma and chronic obstructive pulmonary disease overlap syndrome in tertiary care setting Thailand
por: Kawamatawong, Theerasuk, et al.
Publicado: (2017)

Haematological and Inflammatory Biomarkers Among Stable COPD and Acute Exacerbations of COPD Patients
por: Ramya, Priya A., et al.
Publicado: (2023)

Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD
por: Pinto-Plata, Victor, et al.
Publicado: (2012)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
por: Sim, Yun Su, et al.
Publicado: (2022)

Effects of Oral Procaterol for Postinfectious Cough in Adults: Single-Centre, Randomized Double-Blind, Placebo-Controlled Trial
por: Pornsuriyasak, Prapaporn, et al.
Publicado: (2021)

COPD exacerbations: defining their cause and prevention
por: Wedzicha, Jadwiga A, et al.
Publicado: (2007)

The causes and consequences of seasonal variation in COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2014)

Strategies for improving outcomes of COPD exacerbations
por: Wilkinson, Tom, et al.
Publicado: (2006)

Pulmonary biomarkers in COPD exacerbations: a systematic review
por: Koutsokera, Angela, et al.
Publicado: (2013)

A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation
por: Chen, Yu-Wei Roy, et al.
Publicado: (2016)

Upper-Respiratory Viral Infection, Biomarkers, and COPD Exacerbations
por: Kherad, Omar, et al.
Publicado: (2010)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

The role of serum procalcitonin and CRP levels in determining of etiology and outcome in acute exacerbations of COPD
por: Ceylan, O, et al.
Publicado: (2015)

Do females behave differently in COPD exacerbation?
por: Kilic, Hatice, et al.
Publicado: (2015)

Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation
por: Ban, Andrea, et al.
Publicado: (2012)

Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
por: Ditz, B, et al.
Publicado: (2021)

Phenotyping COPD exacerbations using imaging and blood-based biomarkers
por: Alotaibi, Nawaf M, et al.
Publicado: (2018)

Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific
por: Taddei, Laura, et al.
Publicado: (2022)

Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations
por: Gao, Jie, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators
por: Lu, Fang-Ying, et al.
Publicado: (2021)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

Acute Exacerbation of COPD
por: Lief, Lindsay, et al.
Publicado: (2019)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Acute Exacerbation of COPD
por: Pappas, Dominic, et al.
Publicado: (2023)

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018)

Low serum free light chain is associated with risk of COPD exacerbation
por: Tanimura, Kazuya, et al.
Publicado: (2020)

Subtypes of Patients Experiencing Exacerbations of COPD and Associations with Outcomes
por: Arostegui, Inmaculada, et al.
Publicado: (2014)

Predictors of outcome of noninvasive ventilation in severe COPD exacerbation
por: Steriade, Alexandru T., et al.
Publicado: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v7f795vm5s9mvd1quio4cj2ir5